Invesco Ltd. Selecta Biosciences Inc Transaction History

Invesco Ltd.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$0.62 - $0.85 $117,897 - $161,633	190,157 Added 348.64%	244,699 $205,000
Q4 2023 Feb 12, 2024	SELL	$0.67 - $1.35 $15,741 - $31,718	-23,495 Reduced 30.11%	54,542 $37,000
Q3 2023 Nov 13, 2023	SELL	$1.02 - $1.23 $1,214 - $1,464	-1,191 Reduced 1.5%	78,037 $82,000
Q2 2023 Aug 11, 2023	BUY	$1.04 - $1.4 $61,505 - $82,796	59,140 Added 294.4%	79,228 $88,000
Q1 2023 May 12, 2023	SELL	$1.15 - $1.89 $795 - $1,307	-692 Reduced 3.33%	20,088 $27,000
Q4 2022 Feb 13, 2023	BUY	$0.96 - $1.6 $19,948 - $33,248	20,780 New	20,780 $23,000
Q2 2022 Aug 15, 2022	SELL	$0.67 - $1.4 $20,079 - $41,956	-29,969 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.23 - $3.31 $2,167 - $5,832	1,762 Added 6.25%	29,969 $37,000
Q4 2021 Feb 14, 2022	SELL	$2.89 - $4.43 $14,883 - $22,814	-5,150 Reduced 15.44%	28,207 $92,000
Q3 2021 Nov 15, 2021	BUY	$3.36 - $4.62 $14,175 - $19,491	4,219 Added 14.48%	33,357 $139,000
Q2 2021 Aug 17, 2021	BUY	$2.82 - $5.01 $7,112 - $12,635	2,522 Added 9.48%	29,138 $122,000
Q1 2021 May 17, 2021	BUY	$2.92 - $5.07 $5,527 - $9,597	1,893 Added 7.66%	26,616 $120,000
Q4 2020 Feb 16, 2021	BUY	$1.64 - $3.42 $40,545 - $84,552	24,723 New	24,723 $75,000

4.67M

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.